Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
The industry was working on a number of issues advancing in Congress — including reforming the 340B discount drug program, alleviating supply chain issues and reining in pharmacy benefit managers, which negotiate discounts on drugs and choose which medicines insurance plans will cover.
- Simplified Text
-
The industry was working on issues advancing in Congress
- Confidence Score
- 0.900
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "date": "04\/24\/2024", "topic": "Pharma lobbying", "source": "POLITICO" } - UUID
- a1165f69-4450-49be-bea2-2082dcde99d0
- Vector Index
- ✗ No vector
- Created
- February 15, 2026 at 4:57 PM (2 months ago)
- Last Updated
- February 15, 2026 at 4:57 PM (2 months ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
Completed
News
21
claims
🔥
2 months ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharmaceutical companies increased lobbying spending in the first quarter of 2024. Key issues driving the spending include 340B program reform, supply chain issues, and pharmacy benefit manager regulations. The article also covers Supreme Court arguments on abortion and bird flu fragments in milk.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.